POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Clinical trials for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a smarter chemo dosing beat childhood lymphoma?
Disease control CompletedThis early-phase study tested a chemotherapy regimen called dose-adjusted EPOCH-R in 4 children with certain B-cell cancers (DLBCL, PMBCL, or PTLD). The goal was to see if giving the drugs continuously over 4 days and adjusting doses based on blood cell counts is safe and effecti…
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
Can a simple virus test save transplant patients from cancer?
Knowledge-focused CompletedThis study followed 509 kidney transplant recipients to see if regularly checking Epstein-Barr virus (EBV) levels in blood could help identify those at higher risk for serious infections, a type of cancer called PTLD, or death. Researchers compared virus levels in whole blood ver…
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC